BRCA2 and neoplasm: Furthermore, African American patients show a higher mutation frequency of BRCA1 (10.2%) and BRCA2 (5.7%) tumor suppressor genes comparing to European non-Ashkenazi Jews White patients (BRCA1: 6.9%, BRCA2: 5.2%) [9, 10].